Bioaccumulation of heavy metals in the different tissues of Mackerel scad, Decapterus macarellus (Cuvier, 1833) collected from Karachi and Gwadar Coasts of Pakistan.

Introduction: Among other aquatic animals, fish can also accumulate a large number of toxic metals in their various body organs, which may enter in the human body and cause serious health issues. Therefore, the basic aim of this study was to observe the level of some heavy metals (i.e., Pb, Fe, Cu, Cd, Cr) found in the different tissues of Decapterus macarellus collected from the Karachi and Gwadar coasts of Pakistan. Methods: About 200 fish samples of five different size groups of Decapterus macarellus were collected from Gwadar and Karachi fish harbors during April to September 2020. Total 10 samples of each size group i.e., S1, S2, S3, S4 & S5 were collected from each coast. Heavy metals were analyzed in fish samples by using the atomic absorption spectrophotometer (AAS). Results: The overall results revealed that some metals like Cu, Pb, Cd & Cr contents were high in the stomach, while less in the muscles. Whereas, the concentration of Fe was found to be high in the liver, while low in skin of fish. The average values of bioaccumulation of these heavy metals (BAF) were found in decreasing order of Cu > Cd > Fe > Cr > Pb. In this study, except Cd and Cr, all metals were found within the permissible limits. Both sediment and water from the selected site areas were also analyzed to observe their pollution levels in the order of; sediment > water > fish tissues. Conclusion: Thus, it was concluded that the Karachi environment was much more polluted than the Gwadar environment because it is in an industrial unit and a busy sea site for trade. Moreover, consuming muscles from this species is safe for human health except for iron toxicity, but the use of the liver is not beneficial for all selected metals. Thus, the present work will also be helpful to monitor these toxic metals in a food chain and maintain a healthy life, and reduce all kinds of health risks associated with them.

Bioassay Directed Isolation, Biological Evaluation and in Silico Studies of New Isolates from Pteris cretica L.

Members of genus Pteris have their established role in the traditional herbal medicine system. In the pursuit to identify its biologically active constituents, the specie Pteris cretica L. (P. cretica) was selected for the bioassay-guided isolation. Two new maleates (F9 and CB18) were identified from the chloroform extract and the structures of the isolates were elucidated through their spectroscopic data. The putative targets, that potentially interact with both of these isolates, were identified through reverse docking by using in silico tools PharmMapper and ReverseScreen3D. On the basis of reverse docking results, both isolates were screened for their antioxidant, acetylcholinesterase (AChE) inhibition, α-glucosidase (GluE) inhibition and antibacterial activities. Both isolates depicted moderate potential for the selected activities. Furthermore, docking studies of both isolates were also studied to investigate the binding mode with respective targets followed by molecular dynamics simulations and binding free energies. Thereby, the current study embodies the poly-pharmacological potential of P. cretica.

Therapeutic Uses of HSP90 Inhibitors in Non-Small Cell Lung Carcinoma (NSCLC).

BACKGROUND: Non-Small Cell Lung Carcinoma is one of the major cause of morbidity and mortality worldwide with an incidence rate of 1.3 million cases per year. Heat shock protein 90 (HSP90) is a promising drug target in cancer treatment. HSP90 is required to activate numerous eukaryotic proto-oncogenic protein kinases, hence play a prominent role in cancer. METHOD: We reviewed fifty-five articles to highlight the importance of HSP90 in NSCLC and the recent developments of its inhibitors. RESULTS: This review showed that HSP90 inhibitors i.e. Ganestespib have shown great potential in the treatment of non-small cell lung carcinoma (NSCLC). Different HSP90 inhibitors has been designed till date that acts as effective drugs in tumour suppression. However, the utility of these drugs has been limited due to several drawbacks including hepato-toxicity, poor solubility, and poorly tolerated formulations. CONCLUSION: The goal of this review is to present the data in support of use of HSP90 inhibitors in NSCLC and to provide an overview of the on-going clinical trials involving new-generation HSP90 inhibitors.